No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditions
|
- |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D01
- Name in latin
- Carcinoma in situ ani
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of colon
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of colon
- Carcinoma in situ of other and unspecified digestive organs
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 244 | 110 | 126 |
| Only index persons | 137 | 74 | 63 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 69.31 | 68.60 | 70.00 |
| Only index persons | 65.02 | 64.98 | 65.07 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 438 | 175 | 263 |
| Unadjusted period prevalence (%) | 0.09 | 0.06 | 0.12 |
| Median age at first event (years) | 71.38 | 71.88 | 71.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 393
- Matched controls
- 3930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJF32
NOMESCO Finland
Coloscopy
10.4
96.4
262
635
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
158.0
64.1
66
5
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
15.6
62.2
107
92
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
17.7
61.0
99
73
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
22.6
58.3
86
48
130
Kela drug reimbursment
Malignant tumour
+∞
57.7
54
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
13.0
55.6
104
106
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
21.3
54.5
82
48
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
10.1
47.4
101
130
WX302
NOMESCO Finland
Thoracal epidural anesthesy
22.4
45.0
66
35
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
31.3
44.4
59
22
8263/2-C18.0
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of cecum
+∞
43.5
41
*
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
43.5
43.1
53
14
WX402
NOMESCO Finland
General anaesthesia
6.4
42.7
128
274
C187, 8211, 2
ICD-O-3
NA
+∞
42.5
40
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
39.2
37
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
39.2
37
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
215.7
38.5
39
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.9
34.4
65
64
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
18.4
34.0
53
33
L01BC06
ATC
capecitabine; oral
+∞
33.8
32
*
B01AB05
ATC
enoxaparin; parenteral
3.9
32.1
179
695
8263/2-C18.7
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of sigmoid colon
+∞
31.7
30
*
C189, 8211, 2
ICD-O-3
NA
+∞
31.7
30
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
31.7
30
*
K63.5
ICD-10 Finland
Polyp of colon
32.5
31.4
41
14
A04AA02
ATC
granisetron; systemic, transdermal
338.3
31.3
31
*
JN4AD
NOMESCO Finland
Body CT examination
12.9
31.0
56
50
JN4BD
NOMESCO Finland
Extensive body CT
8.0
28.6
68
100
WF002
NOMESCO Finland
Radical radiotherapy
156.0
28.0
29
*
H02AB02
ATC
dexamethasone; systemic
25.3
28.0
39
17
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
15.4
26.0
43
31
116
Kela drug reimbursment
Prostate cancer
+∞
25.3
24
*
C180, 8211, 2
ICD-O-3
NA
+∞
25.3
24
*
8263/2-C18.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS
+∞
25.3
24
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
25.3
24
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
8.6
24.3
54
71
B01AB10
ATC
tinzaparin; parenteral
7.8
23.5
56
82
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
22.1
21
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
21.7
80
203
C187, 8148, 2
ICD-O-3
NA
+∞
21.0
20
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
21.0
20
*
UJF30
NOMESCO Finland
Ileoscopy through colon
4.8
20.0
71
172
C189, 8148, 2
ICD-O-3
NA
+∞
18.9
18
*
UJF32
SPAT
NA
11.9
18.6
34
31
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.2
18.0
34
33
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
99.6
17.7
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
188.0
17.7
18
*
L02AE02
ATC
leuprorelin; implant, parenteral
66.3
16.9
19
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
3.0
16.8
118
495
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
+∞
16.8
16
*
C180, 8148, 2
ICD-O-3
NA
+∞
16.8
16
*
8211/2-C18.2
ICD-O-3
Tubular adenocarcinoma in situ of ascending colon
+∞
16.8
16
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
16.8
73
214
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
94.1
16.7
18
*
WX600
NOMESCO Finland
Single shot through catheter
177.1
16.6
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.9
15.8
45
84
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
15.7
15
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.7
15
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
15.7
145
718
JFA15
SPAT
NA
30.0
15.3
20
7
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.1
14.7
33
44
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
14.7
14
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
14.7
14
*
8263/2-C18.2
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of ascending colon
+∞
14.7
14
*
Z51.5
ICD-10 Finland
Palliative care
9.6
14.0
28
31
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
13.6
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
13.6
13
*
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
144.7
13.5
14
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
144.7
13.5
14
*
WZC30
NOMESCO Finland
Teaching
3.8
13.4
60
179
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
15.8
13.2
21
14
R4110
NOMESCO Finland
Physiotherapy
2.5
12.6
123
613
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
12.6
12
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
12.6
12
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
12.6
12
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
12.5
121
599
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
134.0
12.5
13
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.0
11.9
48
131
8140/2-C18.7
ICD-O-3
Adenocarcinoma in situ, NOS, of sigmoid colon
+∞
11.5
11
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.2
11.4
62
214
JFB30
NOMESCO Finland
Right hemicolectomy
20.8
11.2
16
8
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
10.9
69
264
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
61.7
10.7
12
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
61.7
10.7
12
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
4.9
10.5
34
75
Y77
ICPC
Malignant neoplasm prostate
112.9
10.5
11
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.5
10
*
L02BB03
ATC
bicalutamide; oral
+∞
10.5
10
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
10.5
10
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
10.5
10
*
A04AA01
ATC
ondansetron; systemic, rectal
8.6
10.5
22
27
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
10.1
35
83
JFF23
NOMESCO Finland
Transversostomy
56.4
9.7
11
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
56.4
9.7
11
*
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
56.4
9.7
11
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
9.6
41
118
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
18.1
9.5
14
8
WF049
NOMESCO Finland
Radiotherapy of metastasis
102.4
9.5
10
*
C188, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
+∞
9.4
9
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
9.4
9
*
C186, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
9.4
9
*
C184, 8148, 2
ICD-O-3
NA
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
9.4
9
*
C184, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
9.4
342
2880
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
9.3
183
1210
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
9.0
83
393
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
8.8
100
523
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
8.8
135
805
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.4
8.6
25
49
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
8.5
96
501
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
8.4
8
*
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
+∞
8.4
8
*
L02BG04
ATC
letrozole; oral
+∞
8.4
8
*
C182, 8148, 2
ICD-O-3
NA
+∞
8.4
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
ZXE00
NOMESCO Finland
One hour or less
1.9
8.2
154
984
C03CA01
ATC
furosemide; systemic
2.0
8.2
137
838
L03AA02
ATC
filgrastim; parenteral
34.1
8.1
10
*
Z2221
NOMESCO Finland
Medical doctor
2.1
7.9
107
603
A02BC02
ATC
pantoprazole; systemic
1.8
7.8
254
1956
D75
ICPC
Malignant neoplasm colon/rectum
45.9
7.7
9
*
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
45.9
7.7
9
*
JAH01
NOMESCO Finland
Laparoscopy
6.9
7.7
18
27
Z3231
NOMESCO Finland
Registered nurse
2.0
7.7
115
674
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.6
7.6
25
57
UJD10
SPAT
NA
10.3
7.6
14
14
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
7.6
148
956
WX110
NOMESCO Finland
Local anesthesy
1.8
7.5
248
1906
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.8
7.5
20
36
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
81.5
7.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
L02BA01
ATC
tamoxifen; oral
+∞
7.3
7
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
7.3
7
*
TQW40
NOMESCO Finland
Remowal of suture of skin
3.3
7.2
34
108
Z01.9
ICD-10 Finland
Special examination, unspecified
3.6
6.7
28
81
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.8
6.5
20
43
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.9
6.4
7
*
D50
ICD-10 Finland
Iron deficiency anaemia
9.5
6.3
12
13
WX892
NOMESCO Finland
Monitored bed care
2.8
6.3
40
154
C90.0
ICD-10 Finland
Multiple myeloma
+∞
6.3
6
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
8263/2-C18.4
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of transverse colon
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.3
6
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
6.3
6
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.9
6.2
16
28
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.9
6.2
24
65
XKD00
NOMESCO Finland
Uroflowmetry
2.1
6.2
71
370
R18
ICD-10 Finland
Ascites
10.2
6.1
11
11
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
10.2
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
292
357
22.54
254.55
1.9
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
235
214
22.54
243.70
5.4
1.5
ug/l
14.5
4.3
0.95
199
163
(40768804) Tissue Pathology biopsy report
277
1022
5.65
70.84
2.6
1.6
—
—
—
0
0
(4035726)
85
109
9.44
64.42
1.3
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
325
1536
5.33
56.80
5.3
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
249
1012
4.38
51.86
3.5
2.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
319
1561
4.84
51.21
7.0
3.8
g/l
34.0
35.4
4.26
307
1433
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
63
82
8.81
46.70
4.2
1.9
u/ml
76.1
76.9
0.00
56
63
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
155
486
4.39
45.03
2.7
2.4
%
16.3
22.6
7.13
137
404
(3004789) Transferrin [Mass/volume] in Serum or Plasma
160
516
4.31
44.71
2.7
2.3
g/l
2.4
2.3
2.03
152
478
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
219
932
3.70
40.11
2.9
2.2
mg/l
3.8
3.0
1.79
189
790
(3022948) Iron [Moles/volume] in Serum or Plasma
163
570
3.96
40.08
2.8
2.3
umol/l
10.2
12.7
4.28
157
520
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
112
306
4.57
38.40
2.6
2.1
g/l
0.2
0.2
1.38
102
275
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
322
1797
3.99
37.97
10.1
4.1
umol/l
13.9
12.2
0.55
309
1687
(3002256) Pathology report gross observation
100
252
4.85
37.90
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
193
785
3.61
37.38
3.1
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
265
1402
3.25
31.93
3.6
2.6
ug/l
113.4
145.1
1.46
244
1269
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
81
210
4.51
29.23
12.1
9.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
278
1593
3.04
27.63
11.8
10.7
inr
1.4
1.3
0.06
87
426
(3023368) Bacteria identified in Blood by Culture
208
1020
2.98
27.53
6.0
3.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
386
2731
4.48
26.04
12.6
5.5
u/l
89.2
76.9
2.64
379
2516
(3012095) Magnesium [Moles/volume] in Serum or Plasma
128
505
3.17
24.50
4.1
2.8
mmol/l
0.8
0.8
1.40
119
462
(3002582) Erythrocytes [#/volume] in Urine
208
1087
2.74
23.47
3.4
3.0
e6/l
56.9
113.3
0.44
149
835
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
101
361
3.34
22.63
3.5
2.9
u/l
239.5
249.5
0.36
101
338
(3013826) Glucose [Moles/volume] in Serum or Plasma
331
2224
3.00
22.22
8.1
4.5
mmol/l
7.1
6.8
1.46
324
2082
(3003396) Base excess in Arterial blood by calculation
120
480
3.07
22.20
10.5
6.4
mmol/l
0.3
1.4
1.93
102
378
(40768797) Stomach Pathology biopsy report
124
507
3.02
22.05
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
193
1000
2.66
21.77
3.3
2.9
e6/l
0.6
0.5
0.36
138
742
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
286
1804
2.69
21.34
10.7
5.8
mmol/l
1.2
1.2
4.11
246
1537
(3018095) Leukocytes [#/volume] in Urine
224
1257
2.60
21.31
4.2
3.6
e6/l
114.4
93.5
0.22
152
898
(3013650) Neutrophils [#/volume] in Blood by Automated count
296
1906
2.71
21.05
13.4
6.0
e9/l
4.3
4.3
0.15
244
1662
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
85
287
3.43
20.74
2.8
2.1
u/l
36.4
33.6
0.33
73
238
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
100
378
3.13
20.24
3.9
2.5
umol/l
10.4
8.3
0.27
87
334
(3000991) Gas panel - Venous blood
89
314
3.30
20.21
13.2
7.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
115
471
2.95
20.21
2.6
2.1
%
1.9
1.8
0.71
107
419
(36304419) Bacteria [Presence] in Urine
183
954
2.58
20.02
3.4
2.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
225
1309
2.48
19.24
3.6
3.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
204
1138
2.48
19.09
7.2
5.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
197
1086
2.48
18.86
4.4
2.8
u/l
50.1
33.8
0.44
185
1027
(3048689) Calprotectin [Mass/mass] in Stool
93
351
3.09
18.78
2.1
2.2
ug/g
222.8
162.3
0.64
77
275
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
126
564
2.73
18.57
3.2
2.9
e6/l
1.2
2.2
1.08
67
300
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
261
1650
2.44
18.21
10.2
5.2
mmol/l
1.2
1.2
2.64
246
1453
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
58
170
3.78
17.40
1.9
1.7
g/l
1.7
1.5
0.97
53
144
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
616
2.61
17.35
3.1
2.6
e6/l
1.0
1.1
0.15
72
347
(3023520) Reticulocytes [#/volume] in Blood
92
360
2.97
17.34
3.0
2.3
e9/l
73.2
68.1
0.55
68
281
(3003694) ABO and Rh group [Type] in Blood
159
823
2.46
17.14
1.4
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
246
1543
2.36
17.08
7.1
5.3
%
0.6
0.7
0.71
228
1432
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
120
4.27
17.02
2.2
2.4
u/ml
0.2
0.4
2.29
21
66
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
204
1193
2.33
16.53
3.3
2.3
u/l
61.2
57.3
0.46
189
1098
(3019069) Monocytes/100 leukocytes in Blood
249
1598
2.29
16.01
7.4
5.6
%
8.9
8.8
0.14
232
1483
(3015377) Calcium [Moles/volume] in Serum or Plasma
195
1132
2.30
15.93
4.7
2.1
mmol/l
2.4
2.3
0.02
173
919
(3006504) Eosinophils/100 leukocytes in Blood
248
1591
2.29
15.93
7.2
5.3
%
2.6
3.0
2.24
230
1472
(3018418) pH of Serum or Plasma
184
1049
2.30
15.62
5.1
3.1
ph
7.4
7.4
1.12
40
166
(3002030) Lymphocytes/100 leukocytes in Blood
251
1630
2.26
15.50
7.6
5.5
%
24.8
26.9
1.77
234
1505
(3031040) Bacteria [#/volume] in Urine by Automated count
324
2349
2.46
15.32
5.5
4.4
e6/l
7.4
2824.0
—
5
41
(3001604) Monocytes [#/volume] in Blood
260
1724
2.25
15.11
7.0
5.1
e9/l
0.6
0.6
0.00
213
1483
(3018010) Neutrophils/100 leukocytes in Blood
248
1614
2.24
15.09
7.2
5.3
%
60.0
57.9
1.73
230
1504
(3019198) Lymphocytes [#/volume] in Blood
263
1758
2.24
14.90
7.4
5.1
e9/l
2.2
1.8
0.44
223
1542
(3006315) Basophils [#/volume] in Blood
260
1733
2.23
14.80
7.0
5.1
e9/l
0.0
0.0
0.86
213
1498
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
66
241
3.05
13.91
1.7
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
420
3556
5.41
13.73
28.5
13.5
mg/l
32.4
24.7
5.06
396
2787
(3021589) Normoblasts [#/volume] in Blood
234
1527
2.14
13.66
16.1
8.2
e9/l
0.0
0.0
0.41
186
1246
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
668
2.32
13.39
1.2
1.2
u/ml
1.8
1.5
0.20
26
183
(3013115) Eosinophils [#/volume] in Blood
261
1788
2.14
13.28
7.3
5.2
e9/l
0.2
0.2
1.84
217
1567
(3037756) Immunofixation for Serum or Plasma
30
65
4.88
13.26
1.5
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
107
518
2.41
12.90
2.6
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
180
1091
2.10
12.45
4.2
3.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
323
2459
2.19
11.78
5.8
4.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
403
3393
3.35
11.71
27.8
12.3
ml/min/173m2
74.3
75.5
0.47
335
2723
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
28
66
4.46
11.19
1.4
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
248
1747
1.97
10.77
4.6
3.7
estimate
0.0
0.0
0.00
57
283
(3007164) IgA [Mass/volume] in Serum or Plasma
114
613
2.16
10.50
1.8
1.3
g/l
2.7
2.9
0.19
55
357
(3003458) Phosphate [Moles/volume] in Serum or Plasma
93
461
2.29
10.44
6.3
4.9
mmol/l
1.0
1.0
0.00
87
417
(3021601) Nitrite [Presence] in Urine by Test strip
247
1750
1.94
10.41
6.6
5.0
estimate
0.0
0.0
0.00
59
281
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
78
359
2.43
10.36
4.6
3.0
—
—
—
0
0
(3015736) pH of Urine
206
1390
1.91
9.90
4.1
3.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
248
1782
1.90
9.78
4.8
3.7
estimate
0.0
0.0
0.00
58
278
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
121
685
2.06
9.64
3.9
2.1
mmol/l
2.5
2.4
2.10
103
585
(3018677) aPTT in Platelet poor plasma by Coagulation assay
110
603
2.10
9.54
2.8
1.8
s
31.6
29.8
0.98
110
577
(40768800) Prostate Pathology biopsy report
16
26
6.35
9.52
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
123
704
2.04
9.49
3.6
2.5
mosm/kgh2o
554.5
553.9
0.01
100
585
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
62
267
2.54
9.46
5.6
2.5
mmol/l
1.2
1.2
0.00
53
223
(3002179) Metamyelocytes/100 leukocytes in Blood
57
236
2.63
9.42
3.2
4.2
%
0.6
0.3
0.64
18
49
(3017181) Myelocytes/100 leukocytes in Blood
61
262
2.54
9.36
3.4
4.1
%
0.9
0.7
0.41
23
64
(3013707) Erythrocyte sedimentation rate by Westergren method
338
2716
2.07
9.32
4.8
4.2
mm/h
16.6
12.9
3.10
314
2474
(3020564) Creatinine [Moles/volume] in Serum or Plasma
427
3837
5.49
8.99
34.1
16.1
umol/l
85.9
81.7
1.65
427
3837
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
136
3.05
8.84
2.3
1.3
g/l
9.3
11.0
1.28
33
112
(3004588) Protein electrophoresis panel - Serum or Plasma
60
264
2.47
8.74
2.9
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
149
2.93
8.65
2.5
1.3
g/l
4.1
3.9
0.22
26
101
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
149
2.93
8.65
2.5
1.3
g/l
7.9
7.6
0.36
27
105
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
149
2.93
8.65
2.5
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
66
306
2.36
8.57
3.4
1.6
g/l
64.3
67.7
3.03
61
272
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
286
2204
1.86
8.52
4.3
3.2
u/l
85.6
53.2
2.90
268
2023
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
86
3.54
8.50
1.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
85
441
2.15
8.43
1.8
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
55
238
2.50
8.29
3.3
4.3
%
0.0
1.7
0.50
19
53
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
239
1760
1.79
8.11
2.4
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
232
1695
1.78
8.08
2.5
2.1
pmol/l
90.8
94.9
0.70
138
847
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
106
613
1.96
7.78
2.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
83
441
2.09
7.70
1.8
1.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
30
98
3.21
7.59
2.4
1.2
g/l
0.0
0.0
0.00
25
90
(3021440) Promyelocytes/100 leukocytes in Blood
55
248
2.39
7.58
3.6
4.2
%
0.0
0.1
1.08
21
58
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
28
88
3.33
7.53
2.1
2.6
g/l
3.7
3.7
0.08
28
82
(3021960) Folate [Moles/volume] in Serum or Plasma
156
1032
1.79
7.48
1.8
1.5
nmol/l
18.7
20.7
1.00
138
869
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
121
2.96
7.45
3.5
1.2
g/l
0.8
0.4
0.24
27
102
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
32
110
3.06
7.44
6.5
1.3
—
1.1
—
0
14
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
30
100
3.15
7.34
2.4
1.2
g/l
0.0
0.0
0.00
25
91
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
245
2.37
7.34
1.8
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
34
4.85
7.22
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
16
7.03
7.18
1.3
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
57
268
2.30
7.14
5.9
3.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
32
113
2.98
7.11
6.6
1.3
mg/l
257.0
45.4
0.54
26
93
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
31
108
3.01
7.05
2.7
1.3
g/l
0.0
0.0
0.00
26
98
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
114
2.95
7.00
6.9
1.3
mg/l
70.6
32.4
0.58
26
95
(3007461) Platelets [#/volume] in Blood
428
3940
4.78
6.79
43.9
20.0
e9/l
241.2
239.9
0.13
416
3820
(3026361) Erythrocytes [#/volume] in Blood
428
3942
4.76
6.74
43.9
20.0
e12/l
4.3
4.5
9.47
414
3805
(3010813) Leukocytes [#/volume] in Blood
428
3942
4.76
6.74
43.9
20.0
e9/l
7.1
6.7
1.06
412
3808
(40760892) CBC W Ordered Manual Differential panel - Blood
114
709
1.82
6.59
5.1
4.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
72
384
2.05
6.57
5.0
3.2
mmol/l
0.8
2.1
1.93
63
313
(40758558) Short blood count panel - Blood
123
785
1.79
6.51
8.9
4.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
119
754
1.79
6.45
2.6
2.3
e6/l
4.1
4.9
0.51
100
652
(3044889) 12 lead EKG panel
322
2673
1.77
6.44
4.9
4.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
82
3.17
6.30
6.4
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
363
3133
1.93
6.28
34.3
14.9
%
37.3
39.5
3.57
245
1996
(3017143) Hepatitis C virus Ab [Presence] in Serum
58
291
2.14
6.20
1.6
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
118
2.75
6.04
2.5
1.3
g/l
34.6
37.3
1.47
26
94
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
138
2.59
5.85
2.7
1.3
g/l
3.6
3.1
1.52
26
103
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
25
88
2.95
5.61
2.2
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
408
3716
2.43
5.48
28.4
13.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
181
1331
1.61
5.48
3.6
3.0
ng/l
1466.2
1272.9
0.28
165
1142
(3028026) IgM [Mass/volume] in Serum or Plasma
43
201
2.26
5.47
2.6
1.3
g/l
1.1
1.2
0.05
37
186
(3017446) Testosterone [Moles/volume] in Serum or Plasma
50
252
2.11
5.29
1.8
2.3
nmol/l
12.2
15.3
1.36
38
223
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
210
1612
1.58
5.24
4.9
4.0
ng/l
26.6
61.6
1.06
166
1214
(1616796) Gas panel - Central venous blood
21
70
3.10
5.17
3.5
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
123
831
1.67
5.17
1.8
1.8
nmol/l
1235.9
1197.5
0.14
92
629
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
104
2.70
5.16
1.3
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
43
208
2.18
5.04
3.6
2.4
%
1.1
1.2
0.36
43
208
(3024928) Oxygen saturation in Venous blood
24
88
2.83
5.02
1.9
3.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
230
2.12
4.97
1.7
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
238
2.09
4.91
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
303
1.97
4.89
1.6
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
84
2.83
4.85
1.2
1.3
ug/g
220.5
298.4
—
10
50
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
371
3300
1.81
4.82
5.0
4.5
mu/l
2.2
2.0
0.63
334
2956
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
57
3.25
4.82
3.3
2.3
e9/l
4.2
4.8
0.60
18
57
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
399
3635
2.10
4.79
5.1
5.1
mmol/l
6.4
6.1
3.28
359
3267
(3011397) Hemoglobin [Presence] in Urine by Test strip
126
873
1.62
4.74
3.6
3.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
58
3.19
4.69
3.7
2.7
%
56.7
59.4
0.38
18
58
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
174
2.23
4.65
1.5
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
191
1464
1.54
4.62
2.2
2.3
nmol/l
75.9
79.1
0.83
165
1260
(3005719) IgG [Mass/volume] in Serum or Plasma
48
251
2.02
4.61
3.2
2.1
g/l
10.9
11.2
0.12
42
230
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
111
753
1.64
4.52
1.8
1.7
mg/l
2.3
1.1
0.75
89
592
(3037121) Protein [Mass/volume] in Urine
29
124
2.43
4.52
4.8
2.3
g/l
0.5
0.3
0.66
18
42
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
134
2.33
4.26
2.1
3.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
13
7.04
4.18
3.6
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
13
7.04
4.18
3.6
3.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
23
4.43
4.11
1.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
42
3.41
4.07
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
220
2.01
4.03
2.7
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
48
3.20
3.96
1.7
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
61
365
1.78
3.92
1.5
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
19
71
2.75
3.87
2.1
2.2
%
64.2
60.8
0.23
19
71
(3045788) Cell count panel - Pleural fluid
11
29
3.87
3.82
1.5
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
124
900
1.53
3.71
5.5
3.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
29
136
2.21
3.70
3.4
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
180
1418
1.46
3.57
4.2
4.0
mg/mmol
8.0
8.0
0.00
126
913
(3011648) Oxygen content in Venous blood
11
31
3.61
3.50
1.4
1.5
%
10.7
10.3
0.08
11
31
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
10
7.09
3.37
1.9
2.2
%
94.1
88.8
—
7
10
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
48
2.98
3.33
1.3
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
33
3.39
3.21
1.2
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
15
5.41
3.20
1.4
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
15
5.41
3.20
1.4
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
168
1336
1.42
3.06
3.1
3.2
mg/l
364.1
182.6
0.25
120
863
(3003327) Ova and parasites identified in Stool by Light microscopy
20
88
2.33
2.98
1.5
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
120
901
1.46
2.97
1.9
1.8
pmol/l
433.7
7787317.3
0.50
99
732
(3028308) Erythrocytes [#/volume] in Pleural fluid
11
35
3.20
2.95
1.5
1.3
e6/l
11879.0
182223.5
—
5
21
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
22
4.15
2.89
1.3
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
9
6.74
2.87
1.5
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
9
6.74
2.87
3.8
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
66
440
1.59
2.84
1.8
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
65
2.52
2.82
4.5
2.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
169
1361
1.39
2.81
3.2
3.2
mmol/l
7.6
7.8
0.15
146
1125
(4281824)
8
18
4.51
2.80
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
31
3.28
2.79
1.5
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
78
2.36
2.78
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
168
1354
1.39
2.77
5.6
3.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
72
2.42
2.76
1.6
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
66
2.48
2.74
3.6
2.5
%
14.3
16.2
—
10
36
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
37
3.02
2.71
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1016
1.41
2.69
1.6
1.6
mmol/l
1.4
1.3
0.47
108
845
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
61
2.51
2.64
1.3
1.5
iu/l
2.0
5.0
—
7
21
(3019060) Gas panel - Arterial blood
46
286
1.68
2.61
5.5
4.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
74
2.35
2.61
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
74
2.35
2.61
1.2
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
11
38
2.94
2.60
1.5
1.3
e6/l
338.2
2728.7
—
5
26
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
25
3.65
2.59
1.6
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
68
467
1.54
2.58
1.3
1.3
titre
555.0
544.7
0.02
16
115
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
300
2676
1.38
2.55
4.0
3.6
pmol/l
15.2
15.0
0.48
268
2390
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
75
2.32
2.54
1.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
33
3.08
2.54
2.6
4.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
33
3.08
2.54
1.6
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
33
3.08
2.54
1.8
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
51
2.60
2.46
1.7
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
124
966
1.40
2.46
5.3
3.9
estimate
0.0
0.0
0.50
53
275
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
47
300
1.63
2.43
4.0
3.8
ng/l
105.4
87.1
0.57
40
260
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
386
3617
1.57
2.41
4.5
4.9
mmol/l
1.4
1.4
0.76
347
3282
(3000012) Reticulocyte production index
9
27
3.38
2.40
1.7
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
58
2.46
2.39
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
52
2.55
2.38
1.2
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
8
6.31
2.38
1.8
3.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
35
2.90
2.32
1.1
1.4
pmol/l
293.3
73.7
—
10
35
(3026493) Urate [Moles/volume] in Serum or Plasma
126
994
1.38
2.30
3.3
2.5
umol/l
8702.9
9733.5
0.06
108
843
(40768806) Pleura Pathology biopsy report
8
23
3.52
2.28
1.6
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
388
3649
1.55
2.27
4.5
4.9
mmol/l
4.3
4.5
3.06
356
3329
(3035285) Chloride [Moles/volume] in Venous blood
15
66
2.32
2.27
4.5
2.3
mmol/l
102.5
105.1
1.31
15
66
(3023419) Bacteria identified in Sputum by Culture
15
66
2.32
2.27
2.7
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
15
66
2.32
2.27
4.5
2.3
mmol/l
4.0
4.1
0.62
15
66
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
375
3504
1.49
2.25
7.3
6.7
mmol/mol
42.6
40.9
2.36
348
3223
(3007853) Bacteria identified in Skin by Aerobe culture
62
431
1.51
2.24
2.4
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
373
3483
1.48
2.23
4.0
4.4
mmol/l
1.4
1.3
1.10
334
3140
(3044941) Cell count panel - Synovial fluid
13
55
2.41
2.14
1.6
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
43
2.60
2.11
1.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
394
3730
1.56
2.10
5.5
5.6
mmol/l
2.4
2.6
4.02
353
3400
(44813793)
6
15
4.04
2.04
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
201
1724
1.31
2.04
5.7
3.9
ug/l
4.4
2.0
0.69
174
1540
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
44
2.54
2.02
1.0
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
44
2.54
2.02
1.2
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
70
2.18
2.00
2.3
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
64
2.23
1.96
4.7
2.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
150
1242
1.32
1.95
2.1
2.2
u/l
156.2
256.0
0.89
136
1155
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
118
944
1.34
1.95
3.8
2.7
ug/l
0.7
0.8
0.12
86
652
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
244
1.61
1.95
5.3
3.7
mmol/l
1.9
2.0
0.03
29
188
(3047189) Immunofixation for 24 hour Urine
5
11
4.58
1.94
1.6
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
11
4.58
1.94
1.4
1.0
—
—
—
0
0
(4062490)
9
33
2.76
1.94
1.2
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
6
16
3.79
1.94
1.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
16
3.79
1.94
2.3
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
34
2.68
1.87
2.2
2.0
—
—
—
0
0
(3009343) pH of Capillary blood
39
256
1.57
1.84
5.3
3.6
ph
7.4
7.4
—
6
28
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
53
2.30
1.82
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
60
2.20
1.79
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
67
2.13
1.78
1.2
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
47
0.00
1.71
0.0
1.2
—
7.7
—
0
29
(3000475) Leukocytes [#/volume] in Synovial fluid
17
90
1.92
1.67
1.5
1.5
e6/l
6972.7
15204.0
0.74
11
65
(3051651) Icteric interference index of Serum or Plasma
6
19
3.19
1.66
4.5
2.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
31
2.61
1.66
3.0
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
25
2.83
1.65
1.6
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
56
2.18
1.62
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
14
3.60
1.62
1.4
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
14
3.60
1.62
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
33
2.45
1.54
4.0
2.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
47
335
1.45
1.54
1.5
1.8
%
1.8
1.7
0.26
42
286
(4024509)
6
21
2.88
1.51
2.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
220
1.54
1.48
1.4
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
52
2.14
1.45
1.8
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
173
1.60
1.44
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
119
1.71
1.40
8.8
4.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
18
104
1.76
1.39
6.3
3.3
—
—
—
0
0
(3013512) EKG study
140
1203
1.24
1.29
5.1
4.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
48
2.11
1.28
2.4
2.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
159
1386
1.23
1.28
4.9
3.8
%
19.3
24.0
5.29
87
675
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
531
0.71
1.25
10.3
7.6
—
—
—
0
0
(4268621)
8
36
2.24
1.25
2.1
2.2
—
—
—
0
0
(3017704) Immunofixation for Urine
6
25
2.42
1.24
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
85
1.79
1.24
1.5
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
78
1.82
1.22
1.6
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
38
2.13
1.19
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
72
1.83
1.16
1.3
1.8
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
20
2.52
1.15
1.0
1.1
—
0.0
—
0
5
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
20
2.52
1.15
2.2
1.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
21
2.40
1.09
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
21
2.40
1.09
2.2
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
32
2.21
1.08
1.9
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
105
1.64
1.07
1.8
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
138
1.55
1.05
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
163
1.50
1.04
1.0
1.2
iu/ml
203.7
99.5
—
8
58
(40768441) Liver Pathology biopsy report
5
22
2.29
1.03
1.0
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
22
2.29
1.03
1.2
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
1.9
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
131
0.53
1.00
2.1
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
23
2.19
0.98
5.2
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
23
2.19
0.98
5.2
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
51
1.78
0.95
1.1
1.3
nmol/l
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
62
1.79
0.95
9.1
5.4
iu/ml
327.6
638.5
—
5
8
(3016018) Differential panel - Cerebral spinal fluid
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
26
188
1.41
0.85
1.5
1.2
u/ml
203.0
290.7
0.44
21
176
(3022313) Gas panel - Capillary blood
27
197
1.39
0.84
5.7
3.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
46
1.75
0.83
5.1
3.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
73
1.66
0.82
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
149
0.60
0.80
1.2
1.4
—
—
—
0
0
(3020891) Body temperature
23
166
1.41
0.77
7.0
4.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
53
1.71
0.76
1.1
1.0
g/l
1.6
1.5
—
9
46
(44790049)
7
39
1.81
0.73
1.6
1.6
—
—
—
0
0
(44790047)
7
39
1.81
0.73
1.6
1.6
—
—
—
0
0
(44790048)
7
39
1.81
0.73
1.6
1.6
—
—
—
0
0
(44806118)
7
39
1.81
0.73
1.6
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
40
1.76
0.71
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
142
0.63
0.71
1.7
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
1.4
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
1.4
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
1.4
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
58
1.56
0.70
1.1
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
144
1.41
0.69
1.1
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
23
170
1.37
0.69
2.7
2.3
ug/l
462.5
618.9
0.20
23
159
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
59
1.54
0.68
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
39
313
1.27
0.68
1.7
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
28
1.79
0.66
3.2
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
521
0.81
0.65
4.9
5.0
%
32.3
32.2
0.02
31
337
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
211
0.70
0.63
1.6
1.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
30
1.67
0.61
1.0
1.7
—
29.0
—
0
8
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
45
375
1.22
0.58
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
35
1.72
0.58
3.0
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
35
1.72
0.58
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
36
1.68
0.57
1.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
150
1.35
0.57
1.5
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
148
0.67
0.56
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
16
116
1.39
0.55
1.5
1.4
g/l
0.3
0.2
1.82
16
111
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
39
1.55
0.53
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
63
1.44
0.52
1.9
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
119
1.36
0.49
1.5
1.4
g/l
1.2
1.2
0.41
16
113
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
85
1.42
0.47
1.3
2.0
pmol/l
211.5
233.1
0.38
12
79
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
11
77
1.44
0.46
1.5
1.2
nmol/l
0.8
0.9
0.18
11
61
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
222
1.23
0.42
7.4
3.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
4.1
—
31.1
—
0
8
(3028433) Virus identified in Specimen by Culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
17
0.00
0.40
0.0
1.2
—
7.5
—
0
17
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
305
2959
1.10
0.39
39.9
18.0
g/l
328.5
332.8
10.65
305
2943
(4094501)
15
116
1.30
0.37
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
81
1.37
0.36
1.1
1.1
—
20.4
—
0
5
(3021788) Differential panel - Synovial fluid
9
71
1.27
0.36
1.8
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
41
1.47
0.36
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
108
1.31
0.35
1.4
1.9
nmol/l
46.8
42.8
0.25
14
100
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
125
0.71
0.35
1.7
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
26
219
1.20
0.34
3.6
2.8
e9/l
5.1
3.8
1.10
20
151
(3039443) Prostate specific Ag panel - Serum or Plasma
6
88
0.68
0.33
1.7
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
90
0.66
0.33
1.8
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
53
1.33
0.31
1.4
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
54
1.30
0.30
2.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
55
1.28
0.30
1.4
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
104
1.26
0.26
2.1
1.9
mg/l
13.3
12.6
0.13
13
98
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
132
1.22
0.26
2.8
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
115
1.22
0.24
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
122
1162
1.07
0.23
3.5
3.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
38
1.32
0.23
2.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
39
1.29
0.23
2.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
39
1.29
0.23
2.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
40
1.25
0.22
2.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
2.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
2.0
1.3
—
—
—
0
0
(4034850)
12
146
0.82
0.22
16.8
11.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
377
0.89
0.22
1.7
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
16.4
—
0
10
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
41
374
1.11
0.21
5.9
3.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
301
0.89
0.19
3.0
2.2
ml/min/173m2
59.2
60.4
0.10
16
123
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
58
1.21
0.18
1.6
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
101
1.19
0.16
1.1
1.3
—
—
—
0
0
(1002224) Polysomnography panel
15
130
1.16
0.16
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
78
0.77
0.15
1.2
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
141
1.14
0.14
3.1
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
345
0.92
0.13
4.0
3.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
113
1.16
0.13
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
113
1.16
0.13
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
186
0.91
0.09
1.3
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
60
0.83
0.08
1.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
88
1.14
0.08
2.7
1.7
—
—
—
0
0
(4010399)
32
303
1.06
0.08
1.7
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
82
843
0.97
0.08
4.9
4.1
kg/l
1.0
1.0
0.47
13
121
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
76
1.05
0.07
1.0
1.2
u/l
99.4
17.2
—
8
67
(3008898) HLA-B27 [Presence]
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
287
1.05
0.05
1.3
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
91
1.10
0.04
1.0
1.2
—
3.2
—
0
11
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
129
0.93
0.03
3.7
2.3
ug/min
110.8
87.4
—
5
75
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
118
0.93
0.03
1.7
2.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
22
212
1.04
0.02
1.2
1.4
—
48.8
—
0
11
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
155
1.03
0.00
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
252
0.99
0.00
4.1
2.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
582
1.00
0.00
1.2
1.2
iu/ml
18.0
39.5
2.26
18
180
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
543
0.99
0.00
1.3
1.2
u/ml
30.7
15.9
0.32
14
187
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
9.8
—
0
9
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
18.0
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
3.6
—
0
6
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
85
0.94
0.00
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4306422)
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
104.4
—
0
8
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.3
—
0
7
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_COLON_EXALLC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_INSITU_COLON_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_COLON_EXALLC – Carcinoma in situ of colon
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data